Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine
NCT00197223
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
6213
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Influenza vaccine
Sponsor
GlaxoSmithKline